Pharma channel feed – Endpoints News

Pharma channel feed

UCB sketches grand plans for new headquarters as it grabs Eli Lilly's abandoned neuro R&D campus

5 years ago

The prospect of an October OK largely closed, Pfizer's Albert Bourla promises not to submit for EUA until November

5 years ago

Vaxart was served a grand jury subpoena in July over its controversial role in OWS-funded preclinical study

5 years ago

Sami Anwar raked in millions of dollars gathering drug trial data at his sites. But it was all a lie — and now he's been sentenced to 28 years

5 years ago

Drowning in litigation, Mallinckrodt becomes third opioid producer to file for bankruptcy

5 years ago

As Trump touts his ‘great’ Covid drugs, the pharma cash flows to Biden, not him

5 years ago

Seattle Genetics? Not anymore. The biotech has shortened its name to Seagen to illustrate global expansion

5 years ago

Opdivo/Yervoy combo flops again in melanoma, but Bristol Myers Squibb also has a new OK to celebrate

5 years ago

Ransomware attack hit clinical trials software player ERT — two weeks later, they’re coming back online

5 years ago

Dems slam drug pricing strategies as 18-month probe comes to an end

5 years ago

A new law could open the door to California's own drug pipeline. The state has its sights set on insulin first

5 years ago

FDA issues final rule allowing importation of drugs from Canada — but also keeps the power to revoke it

5 years ago

Op-ed: Will pharma really pay for Trump’s latest lawless promise to 33 million Medicare beneficiaries? Not likely

5 years ago

#ESMO20: Bristol Myers marks Opdivo's second adjuvant win — eyeing a standard of care gap

5 years ago

#ESMO20: Pushing into frontline, Merck and Bristol Myers duke it out with new slate of GI cancer data

5 years ago

#ESMO20: AstraZeneca aims to spur PROfound shift in prostate cancer treatment with Lynparza OS data

5 years ago

Trump’s HHS claims absolute authority over the FDA, clearing path to a vaccine EUA

5 years ago

#ESMO20: AstraZeneca burnishes Tagrisso's adjuvant NSCLC profile with 'unprecedented' reduction in brain mets. Can they win over skeptics?

5 years ago

Pricing deal collapses over Big Pharma's refusal to issue $100 'cash cards' before the election — report

5 years ago

Seattle Genetics' Astellas-partnered ADC nails confirmatory PhIII in urothelial cancer

5 years ago

A month after losing its lead program, Unity Biotechnology cuts 30% of staff in restructuring

5 years ago

Trump ups the stakes with 'granddaddy of them all' drug pricing executive order. But he could be running out of time

5 years ago

Gilead CEO Dan O'Day's $21B M&A deal to buy Immunomedics gets some harsh reviews

5 years ago

A year out from FDA approval, Vertex looks to expand top-selling CF drug to pediatrics

5 years ago

First page Previous page 250 251 252253254 255 256 Next page Last page